These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 8369524

  • 1. The influence of a novel cyclopropyl antiestrogen (compound 7a) on human breast cancer cells in culture.
    Jain PT, Pento JT, Magarian RA.
    Breast Cancer Res Treat; 1993; 25(3):225-33. PubMed ID: 8369524
    [Abstract] [Full Text] [Related]

  • 2. Antitumor mechanism of action of a cyclopropyl antiestrogen (compound 7b) on human breast cancer cells in culture.
    Jain PT, Pento JT, Magarian RA.
    Cancer Chemother Pharmacol; 1996; 38(3):238-44. PubMed ID: 8646798
    [Abstract] [Full Text] [Related]

  • 3. Antiestrogenic effects of Z-1, 1-dichloro-2,3 diphenyl-2-(4-methoxyphenyl)cyclopropane(5a) on human breast cancer cells in culture.
    Jain PT, Pento JT, Magarian RA.
    Anticancer Res; 1992; 12(3):585-90. PubMed ID: 1622114
    [Abstract] [Full Text] [Related]

  • 4. A comparison of the antitumor activity of two triarylcyclopropyl antiestrogens (compounds 4d and 5c) on human breast cancer cells in culture.
    Jain PT, Pento JT, Magarian RA.
    Anticancer Drugs; 1994 Aug; 5(4):429-36. PubMed ID: 7949247
    [Abstract] [Full Text] [Related]

  • 5. Antitumor activity of a novel antiestrogen (Analog II) on human breast cancer cells.
    Jain PT, Rajah TT, Pento JT.
    Anticancer Drugs; 1997 Nov; 8(10):964-73. PubMed ID: 9436640
    [Abstract] [Full Text] [Related]

  • 6. The influence of antiestrogens on the release of plasminogen activator (uPA) by MDA-MB-231 and MCF-7 breast cancer cells.
    Abidi SM, Howard EW, Dmytryk JJ, Pento JT.
    Clin Exp Metastasis; 1998 Apr; 16(3):235-41. PubMed ID: 9568641
    [Abstract] [Full Text] [Related]

  • 7. Influence of cyclopropyl antiestrogens on the cell cycle kinetics of MCF-7 human breast cancer cells.
    Jain PT, Pento JT, Magarian RA.
    Anticancer Res; 1995 Apr; 15(6B):2529-32. PubMed ID: 8669818
    [Abstract] [Full Text] [Related]

  • 8. Differential influence of antiestrogens on the in vitro release of gelatinases (type IV collagenases) by invasive and non-invasive breast cancer cells.
    Abbas Abidi SM, Howard EW, Dmytryk JJ, Pento JT.
    Clin Exp Metastasis; 1997 Jul; 15(4):432-9. PubMed ID: 9219732
    [Abstract] [Full Text] [Related]

  • 9. The estrogenic and antiestrogenic activities of droloxifene in human breast cancers.
    Kawamura I, Mizota T, Lacey E, Tanaka Y, Manda T, Shimomura K, Kohsaka M.
    Jpn J Pharmacol; 1993 Sep; 63(1):27-34. PubMed ID: 8271528
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Influence of antiestrogens on the invasiveness and laminin attachment of breast cancer cells.
    Rajah TT, Pento JT.
    Cancer Invest; 1999 Sep; 17(1):10-8. PubMed ID: 10999044
    [Abstract] [Full Text] [Related]

  • 12. Additive growth inhibitory effects of ibandronate and antiestrogens in estrogen receptor-positive breast cancer cell lines.
    Journe F, Chaboteaux C, Magne N, Duvillier H, Laurent G, Body JJ.
    Breast Cancer Res; 2006 Sep; 8(1):R2. PubMed ID: 16417650
    [Abstract] [Full Text] [Related]

  • 13. Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells.
    Miller MA, Lippman ME, Katzenellenbogen BS.
    Cancer Res; 1984 Nov; 44(11):5038-45. PubMed ID: 6488162
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Inhibition of hormone-dependent and independent breast cancer cell growth in vivo and in vitro with the antiestrogen toremifene and recombinant human interferon-alpha 2.
    Robinson SP, Goldstein D, Witt PL, Borden EC, Jordan VC.
    Breast Cancer Res Treat; 1990 Feb; 15(2):95-101. PubMed ID: 2138919
    [Abstract] [Full Text] [Related]

  • 16. Bioactivities, estrogen receptor interactions, and plasminogen activator-inducing activities of tamoxifen and hydroxy-tamoxifen isomers in MCF-7 human breast cancer cells.
    Katzenellenbogen BS, Norman MJ, Eckert RL, Peltz SW, Mangel WF.
    Cancer Res; 1984 Jan; 44(1):112-9. PubMed ID: 6537799
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Expression of human estrogen receptor using an efficient adenoviral gene delivery system is able to restore hormone-dependent features to estrogen receptor-negative breast carcinoma cells.
    Lazennec G, Katzenellenbogen BS.
    Mol Cell Endocrinol; 1999 Mar 25; 149(1-2):93-105. PubMed ID: 10375022
    [Abstract] [Full Text] [Related]

  • 19. Differential sensitivity of human breast cancer cell lines to the growth-inhibitory effects of tamoxifen.
    Reddel RR, Murphy LC, Hall RE, Sutherland RL.
    Cancer Res; 1985 Apr 25; 45(4):1525-31. PubMed ID: 3978620
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.